0001104659-22-099236.txt : 20220912 0001104659-22-099236.hdr.sgml : 20220912 20220912160200 ACCESSION NUMBER: 0001104659-22-099236 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220908 FILED AS OF DATE: 20220912 DATE AS OF CHANGE: 20220912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Isett Thomas Francis 3rd CENTRAL INDEX KEY: 0001773100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 221238595 MAIL ADDRESS: STREET 1: C/O IBIO INC. 600 MADISON AVENUE STREET 2: SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 4 1 tm2225675d1_4.xml FORM 4 X0306 4 2022-09-08 0 0001420720 iBio, Inc. IBIO 0001773100 Isett Thomas Francis 3rd C/O IBIO, INC. 8800 HSC PARKWAY BRYAN TX 77807 1 1 0 0 CEO and Executive Chairman Stock Option (right to buy) 0.274 2022-09-08 4 A 0 2000000 0 A 2032-09-07 Common Stock 2000000 2000000 D These options vest ratably in equal monthly instalments over a 36-month period beginning on the date of the grant (September 8, 2022), subject to the conditions of the iBio, Inc. 2020 Omnibus Incentive Compensation Plan, as amended, and the related stock option grant agreement. /s/Thomas F. Isett 2022-09-12